▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3904 by analyst upside · 2026-09-28
IQV
IQVIA Holdings Inc.
Healthcare · Market Cap $45B · P/E 33.7x
ANALYST PRICE TARGET
+2.8%
implied upside to consensus target
Current Price $270.37
Consensus Target $277.94
Bull Target $300.0
Bear Target $247.0
Analysts Covering 18
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
13
Hold
3
Sell
0
52-Week Low $154.5
52-Week High $277.4
YTD Return +20.0%
FUNDAMENTALS
Market Cap $45B
P/E Ratio (TTM) 33.7x
Forward P/E 18.7x
EPS (TTM) $8.03
PEG Ratio 0.98
Dividend Yield N/A
Revenue (TTM) $17.0B
Profit Margin 8.1%
52-WEEK RANGE
52-Week Low $154.5
52-Week High $277.4
Current Price $270.37
Bear Target $247.0
Bull Target $300.0
● Now $270.37 ● Target $277.94
TRADING DATA
Avg Volume 1.4M
YTD Return +20.0%
Analyst Count 18
Consensus Buy
Upside to Target +2.8%
Last Updated 2026-09-28

ANALYST SUMMARY

IQVIA Holdings Inc. (IQV) is currently trading at $270.37 with a Wall Street consensus price target of $277.94, implying potential upside of 2.8% over the next 12 months. 18 analysts currently cover IQV, with a consensus rating of Buy - 84% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $300.0, while the most cautious has a target of $247.0.

IQV operates in the Healthcare sector with a market capitalisation of $45B. The stock is up 20.0% year-to-date and is currently trading near the upper end of its 52-week range of $154.5 – $277.4.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for IQV, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2026-09-17 Building track record
JP Morgan - Reiterated
Overweight → Overweight 2026-07-29 43% win rate (7 calls)
Stifel - Reiterated
Buy → Buy 2026-07-29 Building track record
TD Cowen - Reiterated
Buy → Buy 2026-07-29 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-07-29 Building track record
BMO Capital - Reiterated
Outperform → Outperform 2026-07-29 Building track record
Baird - Reiterated
Outperform → Outperform 2026-07-29 Building track record
Mizuho - Reiterated
Outperform → Outperform 2026-07-13 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
70
out of 100
Coverage depth
22/30
Consensus clarity
26/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →